Attar Eyal C.
CIK 0001789076
SVP, Chief Medical OfficerDirector
Filings
21
Latest Feb 18, 2025
Issuers covered
2
Showing
21 of 21
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 60% | +18.8% | +35.3% | +36.8% | -9.4% |
| 90 days | 5 | 100% | +61.6% | +51.8% | +87.5% | +39.7% |
| 180 days | 5 | 60% | +16.1% | +39.2% | +56.4% | -44.2% |
| 365 days | 5 | 100% | +63.5% | +52.0% | +85.3% | +46.0% |
Issuers
Companies where Attar Eyal C. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| VOR | Vor Biopharma Inc. | 18 | Feb 18, 2025 |
| APRE | Aprea Therapeutics, Inc. | 3 | Jun 7, 2022 |
All filings
21 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|